A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer	IO-resistant sqNSCLC	Recruiting	Phase 3	2026-08-04		NCT07217301

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Innovent Biologics (Suzhou) Co. Ltd.	82
Takeda	163

45 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Cancer Hospital & Institute of Guangzhou Medical University	Guangzhou	China	2
Anhui Provincial Cancer Hospital	Hefei	China	4
Anhui Provincial Hospital	Hefei	China	1
Apex Research	Fair Oaks	United States	1
Beijing Cancer Hospital	Beijing	China	208
BRCR Global	Tamarac	United States	1
Cancer and Blood Specialty Clinic	Los Alamitos	United States	27
Chongqing University Cancer Hospital	Chongqing	China	54
D & H Cancer Research Center	Margate	United States	1
Fujian Cancer Hospital	Fuzhou	China	109
Guangdong Provincial People's Hospital	Guangzhou	China	85
Harbin Medical University Cancer Hospital	Harbin	China	102
Henan Cancer Hospital	Zhengzhou	China	57
Henan Provincial People's Hospital	Zhengzhou	China	45
Jiangsu Province Hospital	Nanjing	China	89
Liaoning Cancer Hospital	Shenyang	China	15
Memorial Care	Fountain Valley	United States	1
Nanjing Drum Tower Hospital	Nanjing	China	52
National Cancer Center	Tokyo	Japan	1
Peking University People's Hospital	Beijing	China	146
Shandong Cancer Hospital	Jinan	China	86
Shanghai Chest Hospital	Shanghai	China	83
Shanghai Pulmonary Hospital	Shanghai	China	72
Sichuan Cancer hospital	Chengdu	China	3
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine	Hangzhou	China	24

Clinical trials